lobbying_activities: 2505289

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2505289	28c01c46-667d-43fc-bd2f-d4269e42a097	Q3	ACG ADVOCACY	2057	LYNDRA THERAPEUTICS, INC.	2020	third_quarter	PHA	Issues related to advanced pharmaceutical and domestic supply chain.	Health & Human Services, Dept of (HHS),White House Office	70000		0	0	2020-10-08T17:20:31.237000-04:00